Immunogenomics studies have been largely limited to individuals of European ancestry, restricting the ability to identify variation in human adaptive immune responses across populations. Inclusion of a greater diversity of individuals in immunogenomics studies will substantially enhance our understanding of human immunology.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Inference of SARS-CoV-2 exposure biomarkers using large-scale T-cell repertoire profiling
Genome Medicine Open Access 12 February 2026
-
Germline polymorphisms in the immunoglobulin kappa and lambda loci underpinning antibody light chain repertoire variability
Nature Communications Open Access 28 November 2025
-
TCR repertoire landscape reveals macrophage-mediated clone deletion in endotoxin tolerance
Inflammation Research Open Access 12 January 2023
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Sirugo, G., Williams, S. M. & Tishkoff, S. A. Cell 177, 1080 (2019).
Ben-Eghan, C. et al. Nature 585, 184–186 (2020).
Choudhury, A. et al. Nature 586, 741–748 (2020).
Retshabile, G. et al. Am. J. Hum. Genet. 102, 731–743 (2018).
Freeman, J. D., Warren, R. L., Webb, J. R., Nelson, B. H. & Holt, R. A. Genome Res. 19, 1817–1824 (2009).
Weinstein, J. A., Jiang, N., White, R. A. III, Fisher, D. S. & Quake, S. R. Science 324, 807–810 (2009).
Boyd, S. D. et al. J. Immunol. 184, 6986–6992 (2010).
Briney, B., Inderbitzin, A., Joyce, C. & Burton, D. R. Nature 566, 393–397 (2019).
Avnir, Y. et al. Sci. Rep. 6, 20842 (2016).
Sharonov, G. V., Serebrovskaya, E. O., Yuzhakova, D. V., Britanova, O. V. & Chudakov, D. M. Nat. Rev. Immunol. 20, 294–307 (2020).
Bashford-Rogers, R. J. M. et al. Nature 574, 122–126 (2019).
Gate, D. et al. Nature 577, 399–404 (2020).
Singh, K. M. et al. Immunogenetics 64, 97–109 (2012).
Dilthey, A., Cox, C., Iqbal, Z., Nelson, M. R. & McVean, G. Nat. Genet. 47, 682–688 (2015).
Scheepers, C. et al. J. Immunol. 194, 4371–4378 (2015).
Watson, C. T. et al. Am. J. Hum. Genet. 92, 530–546 (2013).
Watson, C. T., Glanville, J. & Marasco, W. A. Trends Immunol. 38, 459–470 (2017).
Quintana-Murci, L. Cell 177, 184–199 (2019).
Gadala-Maria, D. et al. Front. Immunol. 10, 129 (2019).
Ralph, D. K. & Matsen, F. A. IV PLOS Comput. Biol. 15, e1007133 (2019).
Corcoran, M. M. et al. Nat. Commun. 7, 13642 (2016).
Zhang, W. et al. Front. Immunol. 7, 457 (2016).
Safonova, Y. & Pevzner, P. A. Front. Immunol. 10, 987 (2019).
Bhardwaj, V., Franceschetti, M., Rao, R., Pevzner, P. A. & Safonova, Y. PLOS Comput. Biol. 16, e1007837 (2020).
Ohlin, M. et al. Front. Immunol. 10, 435 (2019).
Rodriguez, O. L. et al. Front. Immunol. 11, 2136 (2020).
Lefranc, M.-P. et al. Nucleic Acids Res. 43, D413–D422 (2015).
Christley, S. et al. Front. Big Data 3, 22 (2020).
Burton, D. R. Nat. Rev. Immunol. 19, 77–78 (2019).
Wang, Y. et al. Immunogenetics 63, 259–265 (2011).
Greiff, V., Yaari, G. & Cowell, L. G. Curr. Opin. Syst. Biol. 24, 109–119 (2020).
Ioannidis, J. P. A., Powe, N. R. & Yancy, C. J. Am. Med. Assoc. 325, 623–624 (2021).
Severe Covid-19 GWAS Group. et al. N. Engl. J. Med 383, 1522–1534 (2020).
Huang, J. et al. Immunity 45, 1108–1121 (2016).
Robbiani, D. F. et al. Cell 169, 597–609.e11 (2017).
Yuan, M. et al. Science 369, 1119–1123 (2020).
Acknowledgements
We thank Nicky Mulder for comments that greatly improved the manuscript. Y.S. was supported by the National Science Foundation EAGER award (no. 2032783). M.S. is supported by Ministry of Science and Higher Education of the Russian Federation grant no. 075-15-2020-807. A.B.P. and C.D.B. are supported by an award from the National Human Genome Research Institute of the National Institutes of Health (U41HG009649). C.T.W. and O.L.R. are supported in part by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award numbers R24AI138963 and R21AI142590. V.G. is supported by a UiO World-Leading Research Community grant, the UiO:LifeScience Convergence Environment Immunolingo, EU Horizon 2020 iReceptorplus (no. 825821) and a Research Council of Norway FRIPRO project (#300740). V.D.J. was supported by an award from the National Cancer Institute of the National Institutes of Health (K12CA001727). The laboratory of L.Q.-M. is supported by the Institut Pasteur, the Collège de France, the CNRS, the Fondation Allianz-Institut de France and the French Government’s Investissement d’Avenir program, Laboratoires d’Excellence ‘Integrative Biology of Emerging Infectious Diseases’ (ANR-10- LABX-62-IBEID) and ‘Milieu Intérieur’ (ANR-10-LABX-69-01). R.A.A. is supported by the Fogarty International Center of the National Institute of Health under award number D43TW010934. P.K. is supported by the Bill and Melinda Gates Foundation (OPP1113682), National Institute of Allergy and Infectious Diseases (NIAID) (1U19AI109662, U19AI057229, 5R01AI125197), Department of Defense (W81XWH1910235) and Catalyst and Transformational Awards from the Dr. Ralph & Marian Falk Medical Research Trust. C.S. is supported by NIAID of the National Institutes of Health under award number U01AI136677. G.K.H is supported by a grant from the Swedish Research Council (award number 532 2017-00968). S.M. is partially supported by National Science Foundation grants 2041984.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
V.G. declares advisory board positions in aiNET GmbH and Enpicom B.V. P.K. is a co-founder of Inflammatix, Inc. He is also a consultant to Inflammatix, Inc., Vir Biotechnology, Cepheid, and Genentech. G.K.H and M.C. are founders of ImmuneDiscover Sweden AB.
Rights and permissions
About this article
Cite this article
Peng, K., Safonova, Y., Shugay, M. et al. Diversity in immunogenomics: the value and the challenge. Nat Methods 18, 588–591 (2021). https://doi.org/10.1038/s41592-021-01169-5
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41592-021-01169-5
This article is cited by
-
Inference of SARS-CoV-2 exposure biomarkers using large-scale T-cell repertoire profiling
Genome Medicine (2026)
-
Germline polymorphisms in the immunoglobulin kappa and lambda loci underpinning antibody light chain repertoire variability
Nature Communications (2025)
-
Adaptive immune receptor repertoire analysis
Nature Reviews Methods Primers (2024)
-
Investigating immunity
Nature Methods (2024)
-
Improving generalization of machine learning-identified biomarkers using causal modelling with examples from immune receptor diagnostics
Nature Machine Intelligence (2024)